Form 4: Orthofix Medical Inc. Director Charles R. Kummeth Acquires Deferred Stock Units

Director Charles R. Kummeth acquired 8,350 deferred stock units of Orthofix Medical Inc. on January 31, 2024.

Summary

• On January 31, 2024, Charles R. Kummeth, a director of Orthofix Medical Inc., acquired 8,350 deferred stock units.
• The price of the transaction was $13.89 per unit.
• Following the transaction, Kummeth directly owns 23,350 shares of common stock.
• The deferred stock units vest on the earlier of June 30, 2024, or the date of the 2024 annual meeting of stockholders, contingent upon continued service.
• Each deferred stock unit represents a right to receive one share of common stock.
• Vested units will convert into common stock within 45 days of termination of service.

Sentiment

Score: 6

Explanation: The sentiment is neutral as it reflects a standard transaction related to director compensation. It doesn't inherently indicate positive or negative performance.

Positives

• The acquisition of deferred stock units by a director signals confidence in the company's future performance.

Future Outlook

The deferred stock units vest on the earlier of June 30, 2024, or the date of the 2024 annual meeting of stockholders, subject to the reporting person's service through such date.

Industry Context

This filing is a routine disclosure of a director's stock-based compensation, which is a common practice in publicly traded companies to align management's interests with those of shareholders.

Stakeholder Impact

• The acquisition of deferred stock units by a director can be viewed positively by shareholders as it aligns the director's interests with the company's long-term success.

Key Dates